Published in Curr Opin Nephrol Hypertens on March 01, 2006
Recovery of hyperphosphatoninism and renal phosphorus wasting one year after successful renal transplantation. Clin J Am Soc Nephrol (2008) 1.07
FGF-23 Levels before and after Renal Transplantation. J Transplant (2009) 0.93
Clinical impact of hypercalcemia in kidney transplant. Int J Nephrol (2011) 0.80
Persistent high level of fibroblast growth factor 23 as a cause of post-renal transplant hypophosphatemia. Clin Exp Nephrol (2007) 0.80
Phosphate and FGF-23 homeostasis after kidney transplantation. Nat Rev Nephrol (2015) 0.79
Fibroblast growth factor-23 and parathyroid hormone are associated with post-transplant bone mineral density loss. Clin J Am Soc Nephrol (2010) 0.77
Post-renal transplantation hypophosphatemia. Pediatr Nephrol (2009) 0.75
FGF23 in kidney transplant: the strange case of Doctor Jekyll and Mister Hyde. Clin Kidney J (2016) 0.75
FGF23 is associated with early post-transplant hypophosphataemia and normalizes faster than iPTH in living donor renal transplant recipients: a longitudinal follow-up study. Clin Kidney J (2016) 0.75
Vascular calcification, bone and mineral metabolism after kidney transplantation. World J Transplant (2015) 0.75
Beneficial effects of preemptive kidney transplantation on calcium and phosphorus disorders in early post-transplant recipients. Clin Exp Nephrol (2014) 0.75
FGF23 induces left ventricular hypertrophy. J Clin Invest (2011) 7.22
Regulation of fibroblast growth factor-23 signaling by klotho. J Biol Chem (2006) 6.50
Klotho deficiency causes vascular calcification in chronic kidney disease. J Am Soc Nephrol (2010) 4.59
Klotho: a novel phosphaturic substance acting as an autocrine enzyme in the renal proximal tubule. FASEB J (2010) 2.91
The metabolic syndrome and uric acid nephrolithiasis: novel features of renal manifestation of insulin resistance. Kidney Int (2004) 2.89
Postmenopausal hormone use and the risk of nephrolithiasis: results from the Women's Health Initiative hormone therapy trials. Arch Intern Med (2010) 2.89
Association of urinary pH with body weight in nephrolithiasis. Kidney Int (2004) 2.67
Klotho deficiency is an early biomarker of renal ischemia-reperfusion injury and its replacement is protective. Kidney Int (2010) 2.50
Nephrolithiasis-associated bone disease: pathogenesis and treatment options. Kidney Int (2010) 2.35
Isolated C-terminal tail of FGF23 alleviates hypophosphatemia by inhibiting FGF23-FGFR-Klotho complex formation. Proc Natl Acad Sci U S A (2009) 2.23
Low urine pH: a novel feature of the metabolic syndrome. Clin J Am Soc Nephrol (2007) 2.02
Vitamin D receptor agonists increase klotho and osteopontin while decreasing aortic calcification in mice with chronic kidney disease fed a high phosphate diet. Kidney Int (2012) 1.82
Pathophysiologic basis for normouricosuric uric acid nephrolithiasis. Kidney Int (2002) 1.78
Fibroblast growth factor 23 and Klotho: physiology and pathophysiology of an endocrine network of mineral metabolism. Annu Rev Physiol (2013) 1.78
Effect of high protein diet on stone-forming propensity and bone loss in rats. Kidney Int (2003) 1.76
Metabolic syndrome and the risk of calcium stones. Nephrol Dial Transplant (2012) 1.71
Effect of low-carbohydrate high-protein diets on acid-base balance, stone-forming propensity, and calcium metabolism. Am J Kidney Dis (2002) 1.68
Albumin regulates the Na+/H+ exchanger 3 in OKP cells. J Am Soc Nephrol (2003) 1.67
CLINICAL Review #: the role of receptor activator of nuclear factor-kappaB (RANK)/RANK ligand/osteoprotegerin: clinical implications. J Clin Endocrinol Metab (2007) 1.66
Urine composition in type 2 diabetes: predisposition to uric acid nephrolithiasis. J Am Soc Nephrol (2006) 1.66
Klotho: a novel regulator of calcium and phosphorus homeostasis. Pflugers Arch (2011) 1.63
Effect of dietary modification on urinary stone risk factors. Kidney Int (2005) 1.61
Comparison of insulin action on glucose versus potassium uptake in humans. Clin J Am Soc Nephrol (2011) 1.57
Cloning and characterization of the human soluble adenylyl cyclase. Am J Physiol Cell Physiol (2005) 1.54
Hypercalciuria associated with high dietary protein intake is not due to acid load. J Clin Endocrinol Metab (2011) 1.54
Circadian variation in urine pH and uric acid nephrolithiasis risk. Nephrol Dial Transplant (2007) 1.51
Body fat content and distribution and urinary risk factors for nephrolithiasis. Clin J Am Soc Nephrol (2013) 1.51
Biochemical profile of stone-forming patients with diabetes mellitus. Urology (2003) 1.51
Etiological role of estrogen status in renal stone formation. J Urol (2002) 1.48
Long-term combined treatment with thiazide and potassium citrate in nephrolithiasis does not lead to hypokalemia or hypochloremic metabolic alkalosis. Kidney Int (2003) 1.46
Defining hypercalciuria in nephrolithiasis. Kidney Int (2011) 1.44
Metabolic basis for low urine pH in type 2 diabetes. Clin J Am Soc Nephrol (2010) 1.41
Renal ammonium excretion after an acute acid load: blunted response in uric acid stone formers but not in patients with type 2 diabetes. Am J Physiol Renal Physiol (2013) 1.40
Prevalence and spot urine risk factors for renal stones in children taking topiramate. J Pediatr Urol (2013) 1.39
Glucocorticoids acutely increase cell surface Na+/H+ exchanger-3 (NHE3) by activation of NHE3 exocytosis. Am J Physiol Renal Physiol (2005) 1.31
Effect of renal lipid accumulation on proximal tubule Na+/H+ exchange and ammonium secretion. Am J Physiol Renal Physiol (2008) 1.27
The erythropoietin receptor is a downstream effector of Klotho-induced cytoprotection. Kidney Int (2013) 1.27
Renal transport of uric acid: evolving concepts and uncertainties. Adv Chronic Kidney Dis (2012) 1.26
Lipid- and mechanosensitivities of sodium/hydrogen exchangers analyzed by electrical methods. Proc Natl Acad Sci U S A (2004) 1.23
Hypocitraturia and hyperoxaluria after Roux-en-Y gastric bypass surgery. J Urol (2010) 1.22
Luminal Na(+)/H (+) exchange in the proximal tubule. Pflugers Arch (2008) 1.21
Insulin activates Na(+)/H(+) exchanger 3: biphasic response and glucocorticoid dependence. Am J Physiol Renal Physiol (2002) 1.20
Novel insights into the pathogenesis of uric acid nephrolithiasis. Curr Opin Nephrol Hypertens (2004) 1.20
Increased propensity for calcium phosphate kidney stones with topiramate use. Expert Opin Drug Saf (2007) 1.19
Biochemical and stone-risk profiles with topiramate treatment. Am J Kidney Dis (2006) 1.19
Monitoring protein-protein interactions between the mammalian integral membrane transporters and PDZ-interacting partners using a modified split-ubiquitin membrane yeast two-hybrid system. Mol Cell Proteomics (2008) 1.18
Rapid Communication: relative effect of urinary calcium and oxalate on saturation of calcium oxalate. Kidney Int (2004) 1.18
Bisphosphonate-induced hypocalcemia: report of 3 cases and review of literature. Endocr Pract (2006) 1.14
Secreted klotho and chronic kidney disease. Adv Exp Med Biol (2012) 1.13
Role of c-SRC and ERK in acid-induced activation of NHE3. Kidney Int (2002) 1.13
Nephrolithiasis in children. Pediatr Nephrol (2005) 1.12
Activation of dopamine D1-like receptors induces acute internalization of the renal Na+/phosphate cotransporter NaPi-IIa in mouse kidney and OK cells. Am J Physiol Renal Physiol (2004) 1.11
Dopamine acutely decreases apical membrane Na/H exchanger NHE3 protein in mouse renal proximal tubule. Kidney Int (2003) 1.11
Klotho and chronic kidney disease. Contrib Nephrol (2013) 1.11
Ontogeny of NHE8 in the rat proximal tubule. Am J Physiol Renal Physiol (2007) 1.10
Adiponectin promotes functional recovery after podocyte ablation. J Am Soc Nephrol (2013) 1.09
Pharmacotherapy of urolithiasis: evidence from clinical trials. Kidney Int (2010) 1.09
The emerging role of Klotho in clinical nephrology. Nephrol Dial Transplant (2012) 1.08
A sperm-specific Na+/H+ exchanger (sNHE) is critical for expression and in vivo bicarbonate regulation of the soluble adenylyl cyclase (sAC). Proc Natl Acad Sci U S A (2007) 1.08
Steady-state function of the ubiquitous mammalian Na/H exchanger (NHE1) in relation to dimer coupling models with 2Na/2H stoichiometry. J Gen Physiol (2008) 1.07
Reduction of renal triglyceride accumulation: effects on proximal tubule Na+/H+ exchange and urinary acidification. Am J Physiol Renal Physiol (2009) 1.07
Klotho as a potential biomarker and therapy for acute kidney injury. Nat Rev Nephrol (2012) 1.06
Na+/H+ exchangers in renal regulation of acid-base balance. Semin Nephrol (2006) 1.06
Association of urinary sodium/potassium ratio with blood pressure: sex and racial differences. Clin J Am Soc Nephrol (2011) 1.06
Na+/H+ exchangers: physiology and link to hypertension and organ ischemia. Curr Opin Nephrol Hypertens (2005) 1.05
Characterization of the regulation of renal Na+/H+ exchanger NHE3 by insulin. Am J Physiol Renal Physiol (2006) 1.04
Renal and extrarenal actions of Klotho. Semin Nephrol (2013) 1.04
Characterization of the sodium/hydrogen exchanger NHA2. J Am Soc Nephrol (2008) 1.02
Nephrolithiasis in topiramate users. Urol Res (2010) 1.01
Shank2 associates with and regulates Na+/H+ exchanger 3. J Biol Chem (2005) 1.01
Uric acid nephrolithiasis. Urol Clin North Am (2007) 1.01
Acute regulation of Na/H exchanger NHE3 by adenosine A(1) receptors is mediated by calcineurin homologous protein. J Biol Chem (2003) 1.00
Postpneumonectomy lung expansion elicits hypoxia-inducible factor-1alpha signaling. Am J Physiol Lung Cell Mol Physiol (2007) 1.00
Characterization of Na+/H+ exchanger NHE8 in cultured renal epithelial cells. Am J Physiol Renal Physiol (2007) 1.00
Minimal change disease with acute renal failure: a case against the nephrosarca hypothesis. Nephrol Dial Transplant (2004) 0.98
Dual role of citrate in mammalian urine. Curr Opin Nephrol Hypertens (2006) 0.97
Expression of epidermal growth factor and surfactant proteins during postnatal and compensatory lung growth. Am J Physiol Lung Cell Mol Physiol (2002) 0.96
Klotho and kidney disease. J Nephrol (2010) 0.95
A case of chromosome 22q11 deletion syndrome diagnosed in a 32-year-old man with hypoparathyroidism. J Clin Endocrinol Metab (2004) 0.94
The dopamine precursor L-dihydroxyphenylalanine is transported by the amino acid transporters rBAT and LAT2 in renal cortex. Am J Physiol Renal Physiol (2004) 0.92
OKP cells express the Na-dicarboxylate cotransporter NaDC-1. Am J Physiol Cell Physiol (2004) 0.91
Calcineurin homologous protein: a multifunctional Ca2+-binding protein family. Am J Physiol Renal Physiol (2011) 0.91
Biochemical distinction between hyperuricosuric calcium urolithiasis and gouty diathesis. Urology (2002) 0.90
Regulated expression of hypoxia-inducible factors during postnatal and postpneumonectomy lung growth. Am J Physiol Lung Cell Mol Physiol (2005) 0.90
Concurrent primary hyperparathyroidism and humoral hypercalcemia of malignancy in a patient with clear cell endometrial cancer. South Med J (2008) 0.90